Henry ScheinSTU:HS2 +1.36%75 PB Ratio is 3.02 as of Jun. 27, 2026, which is 1% above its 10-year median of 3.00. GuruFocus rates STU:HS2 with a GF Score™ of 75/100 and a GF Value™ of €73.24 (Fairly Valued). The stock has 8 warning signs investors should review. Among 112 Medical Distribution companies, Henry Schein ranks worse than 78.57% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-27), Henry Schein's share price is €74.50. Henry Schein's Book Value per Share for the quarter that ended in Mar. 2026 was €24.69. Hence, Henry Schein's PB Ratio of today is 3.02.
Warning Sign:
Henry Schein Inc stock PB Ratio (=2.98) is close to 3-year high of 2.98.
The historical rank and industry rank for Henry Schein's PB Ratio or its related term are showing as below:
STU:HS2'
s PB Ratio Range Over the Past 10 Years
Min: 2.15 Med: 3 Max: 4.17
Current: 2.98
During the past 13 years, Henry Schein's highest PB Ratio was 4.17. The lowest was 2.15. And the median was 3.00.
STU:HS2's PB Ratio is ranked worse than 78.57% of 112
companies
in the Medical Distribution industry
Industry Median: 1.03
vs STU:HS2: 2.98
During the past 12 months, Henry Schein's average Book Value Per Share Growth Rate was 5.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Henry Schein was 77.50% per year. The lowest was -10.90% per year. And the median was 8.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Henry Schein PB Ratio Related Terms
Henry Schein PB Ratio Historical Data
* Premium members only.
The historical data trend for Henry Schein's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Henry Schein's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's PB Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Henry Schein's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Henry Schein (STU:HS2) has a PB Ratio of 3.02 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Henry Schein and its competitors. This is near median its historical median of 3.00. Over the past decade, Henry Schein's PB Ratio has ranged from 2.15 to 4.17. According to the industry distribution chart, Henry Schein ranks #88 out of 112 companies in the Medical Distribution industry, placing it in the top 78.6%.
Is Henry Schein's PB Ratio too high?
Henry Schein's current PB Ratio of 3.02 is near median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 2.15 to a high of 4.17. The Medical Distribution industry median PB Ratio is 1.03. Henry Schein's value of 3.02 is 193.2% above this industry median. Based on the distribution chart, Henry Schein ranks #88 out of 112 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Henry Schein has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's PB Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #88 out of 112 companies for PB Ratio. This places Henry Schein in the lower half of its industry. The industry median PB Ratio is 1.03. Henry Schein's value of 3.02 is 193.2% above this benchmark. Historically, Henry Schein's own PB Ratio has ranged from 2.15 to 4.17 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 1.03, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.03, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current PB Ratio of 3.02 is 193.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current PB Ratio is 3.02, which is near median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (STU:HS2) is currently considered Fairly Valued. The stock's GF Value™ is €73.24, compared to a current price of €74.50 — trading 1.7% above its estimated fair value. The current PB Ratio is 3.02, which is near median its 10-year median of 3.00 and 193.2% above the Medical Distribution industry median of 1.03. Henry Schein's overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Henry Schein (STU:HS2), the current PB Ratio is 3.02 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (STU:HS2) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of €74.50 is trading 1.7% above its estimated GF Value™ of €73.24.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for STU:HS2:
PB Ratio: 3.02 (near median its 10-year median of 3.00)
GF Value™: €73.24 vs. price of €74.50 (1.7% above fair value)
Industry Position: 193.2% above the Medical Distribution median (#88 of 112)
No single metric tells the full story. See the STU:HS2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
75GF Score
Get the complete analysis for STU:HS2
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:HS2 has been successfully added to your 
